AKSO HEALTH GR. (SPADR)/3 (8HX) — Capital Reinvestment Ratio

Latest as of March 2025: 0.13x

AKSO HEALTH GR. (SPADR)/3 (8HX) has a Capital Reinvestment Ratio of 0.13x as of March 2025, meaning it reinvests 0% of its operating cash flow (€1.18 Million) in capital expenditures (€154.46K). See AKSO HEALTH GR. (SPADR)/3 balance sheet quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.13x
Capex / Operating Cash Flow

Operating Cash Flow

€1.18 Million
EUR

Capital Expenditures

€154.46K
EUR

Data as of

Mar 2025
Most recent filing

AKSO HEALTH GR. (SPADR)/3 Capital Reinvestment Ratio (2025–2025)

This chart tracks AKSO HEALTH GR. (SPADR)/3's Capital Reinvestment Ratio across 1 annual periods. Check AKSO HEALTH GR. (SPADR)/3 total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for AKSO HEALTH GR. (SPADR)/3 (2025–2025)

Year-by-year Capital Reinvestment Ratio for AKSO HEALTH GR. (SPADR)/3 from 2025 to 2025. For live market cap and broader valuation context, see AKSO HEALTH GR. (SPADR)/3 stock valuation.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2025 0.13x €1.18 Million €154.46K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow